Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

USANA expansion

This article was originally published in The Tan Sheet

Executive Summary

Direct marketer's entry into Taiwan slated for Q4. Company putting infrastructure in place and obtaining product approvals, also plans to leverage existing resources in Hong Kong, Australia to support Taiwan entry. One-time costs associated with suspended effort to take direct marketer private result in Q1 earnings per share impact of 3¢, USANA says April 25. Nevertheless, net earnings rose 140% from year-ago quarter to $1.1 mil. on a 3.7% sales gain to $28.6 mil. Improved margins resulted from production efficiencies, adjustment in pricing strategy, firm explains. USANA founder Myron Wentz cited company's improved performance as reason for terminating his bid to take it private (1"The Tan Sheet" April 15, 2002, p. 5)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094016

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel